Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5387)
All Articles published online
|
Publishing Process of This Article
|
Apr 15, 2016 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Seldon CS, Colbert LE, Hall WA, Fisher SB, Yu DS, Landry JC. Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomas. World J Gastrointest Oncol 2016; 8(4): 358-365 [PMID: 27096031 DOI: 10.4251/wjgo.v8.i4.358] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v8/i4/358.htm |
| Number | Citing Articles |
| 1 |
Bo Yang, Lili Fu, Jamie R. Privratsky, Xiaohan Lu, Jiafa Ren, Changlin Mei, Steven D. Crowley. Interleukin-1 receptor activation aggravates autosomal dominant polycystic kidney disease by modulating regulated necrosis. American Journal of Physiology-Renal Physiology 2019; 317(2): F221 doi: 10.1152/ajprenal.00104.2019
|
| 2 |
Sofie Martens, Jolien Bridelance, Ria Roelandt, Peter Vandenabeele, Nozomi Takahashi. MLKL in cancer: more than a necroptosis regulator. Cell Death & Differentiation 2021; 28(6): 1757 doi: 10.1038/s41418-021-00785-0
|
| 3 |
Sofie Martens, Nozomi Takahashi, Gillian Blancke, Niels Vandamme, Hanne Verschuere, Tatyana Divert, Marnik Vuylsteke, Geert Berx, Peter Vandenabeele. MLKL deficiency in BrafV600EPten−/− melanoma model results in a modest delay of nevi development and reduced lymph node dissemination in male mice. Cell Death & Disease 2022; 13(4) doi: 10.1038/s41419-022-04819-4
|
| 4 |
Zhen Wang, Li-min Guo, Shu-chao Wang, Dan Chen, Jie Yan, Feng-xia Liu, Ju-fang Huang, Kun Xiong. Progress in studies of necroptosis and its relationship to disease processes. Pathology - Research and Practice 2018; 214(11): 1749 doi: 10.1016/j.prp.2018.09.002
|
| 5 |
Aibin Liu, Yanyan Li, Lin Shen, Na Li, Liangfang Shen, Zhanzhan Li. Pan-cancer analysis of a novel indicator of necroptosis with its application in human cancer. Aging 2022; 14(18): 7587 doi: 10.18632/aging.204307
|
| 6 |
Victor Tetz, George Tetz. Bacterial DNA induces the formation of heat-resistant disease-associated proteins in human plasma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-54618-9
|
| 7 |
Li Xu, Hui Peng, Xiao-Xu Huang, Ya-Bin Xia, Kai-Feng Hu, Zheng-Ming Zhang. Decreased expression of chromodomain helicase DNA-binding protein 9 is a novel independent prognostic biomarker for colorectal cancer. Brazilian Journal of Medical and Biological Research 2018; 51(9) doi: 10.1590/1414-431x20187588
|
| 8 |
Fu Peng, Minru Liao, Rui Qin, Shiou Zhu, Cheng Peng, Leilei Fu, Yi Chen, Bo Han. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduction and Targeted Therapy 2022; 7(1) doi: 10.1038/s41392-022-01110-y
|
| 9 |
Yibo Ma, Qihang Yuan, Shiping He, Xiulin Mao, Shuo Zheng, Changjian Chen. Characterizing the prognostic and therapeutic value of necroptosis in sarcoma based on necroptosis subtypes. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.980209
|